Characteristics | Mean survival time (months) | 95% confidence interval (months) | P values* |
---|---|---|---|
Age (years) | Â | Â | Â |
<47 (n = 37) | 33.98 ± 3.67 | 26-41 | 0.324 |
≥47 (n = 39) | 26.63 ± 3.16 | 20-32 |  |
Gender | Â | Â | Â |
Male (n = 52) | 31.46 ± 3.09 | 25-37 | 0.985 |
Female (n = 24) | 25.92 ± 3.41 | 19-32 |  |
Histological grade | Â | Â | Â |
High grade (WHO III-IV) (n = 41) | 13.61 ± 1.47 | 10-16 | 0.001 |
Low grade (WHO I-II) (n = 35) | 52.45 ± 2.31 | 47-56 |  |
Tumor recurrence | Â | Â | Â |
No (n = 57) | 30.49 ± 3.01 | 24-36 | 0.672 |
Yes (n = 19) | 30.42 ± 4.13 | 22-38 |  |
HGF expression | Â | Â | Â |
High expression (n = 45) | 21.46 ± 2.93 | 15-27 | 0.001 |
Low expression (n =31) | 43.67 ± 3.04 | 37-49 |  |
Cell proliferation | Â | Â | Â |
High PI (n = 43) | 14.41 ± 1.60 | 11-17 | 0.001 |
Low PI (n = 33) | 53.44 ± 2.13 | 49-57 |  |
Intratumoral microvessel density | Â | Â | Â |
≥ Mean IMD value (n = 27) | 24.46 ± 4.05 | 16-32 | 0.079 |
< Mean IMD value (n = 49) | 34.55 ± 3.13 | 28-40 |  |